EQUASENS (EQS.PA) Stock Fundamental Analysis

EPA:EQS • FR0012882389

36.55 EUR
+0.05 (+0.14%)
Last: Feb 13, 2026, 07:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership
Fundamental Rating

6

We assign a fundamental rating of 6 out of 10 to EQS. EQS was compared to 11 industry peers in the Health Care Technology industry. EQS has an excellent profitability rating, but there are some minor concerns on its financial health. EQS is valued quite cheap, while showing a decent growth score. This is a good combination! EQS also has an excellent dividend rating. With these ratings, EQS could be worth investigating further for value and dividend investing!.


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

  • EQS had positive earnings in the past year.
  • In the past year EQS had a positive cash flow from operations.
  • In the past 5 years EQS has always been profitable.
  • EQS had a positive operating cash flow in each of the past 5 years.
EQS.PA Yearly Net Income VS EBIT VS OCF VS FCFEQS.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M

1.2 Ratios

  • EQS has a Return On Assets of 8.82%. This is in the better half of the industry: EQS outperforms 72.73% of its industry peers.
  • The Return On Equity of EQS (15.77%) is better than 90.91% of its industry peers.
  • The Return On Invested Capital of EQS (12.84%) is better than 90.91% of its industry peers.
  • EQS had an Average Return On Invested Capital over the past 3 years of 15.18%. This is significantly above the industry average of 8.41%.
Industry RankSector Rank
ROA 8.82%
ROE 15.77%
ROIC 12.84%
ROA(3y)11.42%
ROA(5y)11.3%
ROE(3y)20.52%
ROE(5y)21.51%
ROIC(3y)15.18%
ROIC(5y)16.08%
EQS.PA Yearly ROA, ROE, ROICEQS.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15 20

1.3 Margins

  • Looking at the Profit Margin, with a value of 16.13%, EQS belongs to the top of the industry, outperforming 81.82% of the companies in the same industry.
  • EQS's Profit Margin has been stable in the last couple of years.
  • EQS has a better Operating Margin (20.02%) than 81.82% of its industry peers.
  • In the last couple of years the Operating Margin of EQS has declined.
  • With a Gross Margin value of 68.81%, EQS perfoms like the industry average, outperforming 45.45% of the companies in the same industry.
  • EQS's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 20.02%
PM (TTM) 16.13%
GM 68.81%
OM growth 3Y-8.16%
OM growth 5Y-4.74%
PM growth 3Y-6.19%
PM growth 5Y-1.37%
GM growth 3Y-0.25%
GM growth 5Y0.16%
EQS.PA Yearly Profit, Operating, Gross MarginsEQS.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

6

2. Health

2.1 Basic Checks

  • EQS has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
  • EQS has about the same amout of shares outstanding than it did 1 year ago.
  • Compared to 5 years ago, EQS has more shares outstanding
  • Compared to 1 year ago, EQS has an improved debt to assets ratio.
EQS.PA Yearly Shares OutstandingEQS.PA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M
EQS.PA Yearly Total Debt VS Total AssetsEQS.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

2.2 Solvency

  • EQS has an Altman-Z score of 3.66. This indicates that EQS is financially healthy and has little risk of bankruptcy at the moment.
  • The Altman-Z score of EQS (3.66) is better than 72.73% of its industry peers.
  • The Debt to FCF ratio of EQS is 0.98, which is an excellent value as it means it would take EQS, only 0.98 years of fcf income to pay off all of its debts.
  • The Debt to FCF ratio of EQS (0.98) is better than 72.73% of its industry peers.
  • A Debt/Equity ratio of 0.09 indicates that EQS is not too dependend on debt financing.
  • EQS has a better Debt to Equity ratio (0.09) than 63.64% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.09
Debt/FCF 0.98
Altman-Z 3.66
ROIC/WACC1.64
WACC7.82%
EQS.PA Yearly LT Debt VS Equity VS FCFEQS.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M

2.3 Liquidity

  • A Current Ratio of 1.29 indicates that EQS should not have too much problems paying its short term obligations.
  • EQS has a Current ratio (1.29) which is comparable to the rest of the industry.
  • EQS has a Quick Ratio of 1.20. This is a normal value and indicates that EQS is financially healthy and should not expect problems in meeting its short term obligations.
  • EQS has a Quick ratio (1.20) which is in line with its industry peers.
Industry RankSector Rank
Current Ratio 1.29
Quick Ratio 1.2
EQS.PA Yearly Current Assets VS Current LiabilitesEQS.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. Growth

3.1 Past

  • EQS shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -13.90%.
  • The Earnings Per Share has been growing slightly by 5.12% on average over the past years.
  • Looking at the last year, EQS shows a small growth in Revenue. The Revenue has grown by 4.45% in the last year.
  • EQS shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 6.45% yearly.
EPS 1Y (TTM)-13.9%
EPS 3Y-2.55%
EPS 5Y5.12%
EPS Q2Q%0.43%
Revenue 1Y (TTM)4.45%
Revenue growth 3Y3.93%
Revenue growth 5Y6.45%
Sales Q2Q%7.39%

3.2 Future

  • The Earnings Per Share is expected to grow by 14.19% on average over the next years. This is quite good.
  • Based on estimates for the next years, EQS will show a small growth in Revenue. The Revenue will grow by 7.74% on average per year.
EPS Next Y11.67%
EPS Next 2Y15.06%
EPS Next 3Y14.19%
EPS Next 5YN/A
Revenue Next Year9.72%
Revenue Next 2Y9.5%
Revenue Next 3Y5.96%
Revenue Next 5Y7.74%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
EQS.PA Yearly Revenue VS EstimatesEQS.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 100M 200M 300M
EQS.PA Yearly EPS VS EstimatesEQS.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 1 2 3

More info and screens

Find the best growth stocksShow best growing peers

7

4. Valuation

4.1 Price/Earnings Ratio

  • With a Price/Earnings ratio of 15.23, EQS is valued correctly.
  • 81.82% of the companies in the same industry are more expensive than EQS, based on the Price/Earnings ratio.
  • EQS's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 27.97.
  • With a Price/Forward Earnings ratio of 12.04, EQS is valued correctly.
  • 81.82% of the companies in the same industry are more expensive than EQS, based on the Price/Forward Earnings ratio.
  • The average S&P500 Price/Forward Earnings ratio is at 27.96. EQS is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 15.23
Fwd PE 12.04
EQS.PA Price Earnings VS Forward Price EarningsEQS.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, EQS is valued cheaply inside the industry as 81.82% of the companies are valued more expensively.
  • Based on the Price/Free Cash Flow ratio, EQS is valued a bit cheaper than the industry average as 72.73% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 14.86
EV/EBITDA 7.21
EQS.PA Per share dataEQS.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15

4.3 Compensation for Growth

  • The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
  • EQS has a very decent profitability rating, which may justify a higher PE ratio.
  • A more expensive valuation may be justified as EQS's earnings are expected to grow with 14.19% in the coming years.
PEG (NY)1.3
PEG (5Y)2.97
EPS Next 2Y15.06%
EPS Next 3Y14.19%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

7

5. Dividend

5.1 Amount

  • EQS has a Yearly Dividend Yield of 3.42%.
  • Compared to an average industry Dividend Yield of 2.30, EQS pays a bit more dividend than its industry peers.
  • EQS's Dividend Yield is rather good when compared to the S&P500 average which is at 1.79.
Industry RankSector Rank
Dividend Yield 3.42%

5.2 History

  • The dividend of EQS is nicely growing with an annual growth rate of 8.00%!
Dividend Growth(5Y)8%
Div Incr Years1
Div Non Decr Years2
EQS.PA Yearly Dividends per shareEQS.PA Yearly Dividends per shareYearly Dividends per share 2023 2024 2025 0.2 0.4 0.6 0.8 1

5.3 Sustainability

  • EQS pays out 51.82% of its income as dividend. This is a bit on the high side, but may be sustainable.
  • EQS's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP51.82%
EPS Next 2Y15.06%
EPS Next 3Y14.19%
EQS.PA Yearly Income VS Free CF VS DividendEQS.PA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M
EQS.PA Dividend Payout.EQS.PA Dividend Payout, showing the Payout Ratio.EQS.PA Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

EQUASENS

EPA:EQS (2/13/2026, 7:00:00 PM)

36.55

+0.05 (+0.14%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Earnings (Last)02-05
Earnings (Next)04-29
Inst Owners11.7%
Inst Owner ChangeN/A
Ins Owners0.2%
Ins Owner ChangeN/A
Market Cap554.46M
Revenue(TTM)224.73M
Net Income(TTM)36.26M
Analysts83.33
Price Target54.06 (47.91%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 3.42%
Yearly Dividend1.25
Dividend Growth(5Y)8%
DP51.82%
Div Incr Years1
Div Non Decr Years2
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)3.25%
PT rev (3m)8.16%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-1.17%
EPS NY rev (3m)-1.17%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 15.23
Fwd PE 12.04
P/S 2.47
P/FCF 14.86
P/OCF 11.37
P/B 2.41
P/tB 6.94
EV/EBITDA 7.21
EPS(TTM)2.4
EY6.57%
EPS(NY)3.04
Fwd EY8.3%
FCF(TTM)2.46
FCFY6.73%
OCF(TTM)3.22
OCFY8.8%
SpS14.81
BVpS15.16
TBVpS5.27
PEG (NY)1.3
PEG (5Y)2.97
Graham Number28.61
Profitability
Industry RankSector Rank
ROA 8.82%
ROE 15.77%
ROCE 15.76%
ROIC 12.84%
ROICexc 18.12%
ROICexgc 70.2%
OM 20.02%
PM (TTM) 16.13%
GM 68.81%
FCFM 16.6%
ROA(3y)11.42%
ROA(5y)11.3%
ROE(3y)20.52%
ROE(5y)21.51%
ROIC(3y)15.18%
ROIC(5y)16.08%
ROICexc(3y)19.08%
ROICexc(5y)21.2%
ROICexgc(3y)48.92%
ROICexgc(5y)61.81%
ROCE(3y)18.64%
ROCE(5y)19.75%
ROICexgc growth 3Y-28.73%
ROICexgc growth 5Y-12.2%
ROICexc growth 3Y-17.5%
ROICexc growth 5Y-11.29%
OM growth 3Y-8.16%
OM growth 5Y-4.74%
PM growth 3Y-6.19%
PM growth 5Y-1.37%
GM growth 3Y-0.25%
GM growth 5Y0.16%
F-Score7
Asset Turnover0.55
Health
Industry RankSector Rank
Debt/Equity 0.09
Debt/FCF 0.98
Debt/EBITDA 0.32
Cap/Depr 70.06%
Cap/Sales 5.11%
Interest Coverage 250
Cash Conversion 79.48%
Profit Quality 102.89%
Current Ratio 1.29
Quick Ratio 1.2
Altman-Z 3.66
F-Score7
WACC7.82%
ROIC/WACC1.64
Cap/Depr(3y)96.13%
Cap/Depr(5y)118.08%
Cap/Sales(3y)6.18%
Cap/Sales(5y)7.08%
Profit Quality(3y)94.47%
Profit Quality(5y)93.6%
High Growth Momentum
Growth
EPS 1Y (TTM)-13.9%
EPS 3Y-2.55%
EPS 5Y5.12%
EPS Q2Q%0.43%
EPS Next Y11.67%
EPS Next 2Y15.06%
EPS Next 3Y14.19%
EPS Next 5YN/A
Revenue 1Y (TTM)4.45%
Revenue growth 3Y3.93%
Revenue growth 5Y6.45%
Sales Q2Q%7.39%
Revenue Next Year9.72%
Revenue Next 2Y9.5%
Revenue Next 3Y5.96%
Revenue Next 5Y7.74%
EBIT growth 1Y-7%
EBIT growth 3Y-4.55%
EBIT growth 5Y1.4%
EBIT Next Year55.72%
EBIT Next 3Y25.38%
EBIT Next 5YN/A
FCF growth 1Y-36.45%
FCF growth 3Y-1.08%
FCF growth 5Y8.7%
OCF growth 1Y-30.97%
OCF growth 3Y0.02%
OCF growth 5Y3.18%

EQUASENS / EQS.PA FAQ

What is the ChartMill fundamental rating of EQUASENS (EQS.PA) stock?

ChartMill assigns a fundamental rating of 6 / 10 to EQS.PA.


What is the valuation status of EQUASENS (EQS.PA) stock?

ChartMill assigns a valuation rating of 7 / 10 to EQUASENS (EQS.PA). This can be considered as Undervalued.


What is the profitability of EQS stock?

EQUASENS (EQS.PA) has a profitability rating of 7 / 10.


Can you provide the PE and PB ratios for EQS stock?

The Price/Earnings (PE) ratio for EQUASENS (EQS.PA) is 15.23 and the Price/Book (PB) ratio is 2.41.


What is the expected EPS growth for EQUASENS (EQS.PA) stock?

The Earnings per Share (EPS) of EQUASENS (EQS.PA) is expected to grow by 11.67% in the next year.